Stay at the forefront of In Silico drug discovery
Identifying metabolites and assessing safety risks can be a slow and resource-heavy hurdle. This year we re-launch Meteor, our solution for confidently understanding the metabolic profile of your compound. Our launch involves hosting educational webinars and in person sessions to share knowledge and interact with our community.
By becoming a Lhasa member, you’ll gain access to integrated workflows that connect metabolite prediction directly to safety endpoints, helping your organisation reduce downstream failures and accelerate risk triage before the costs mount.
What These Sessions will Cover
Our events focus on the practical application of Meteor and Derek Nexus to streamline your discovery pipeline. By registering your interest, you’ll be the first to know about sessions covering:
-
Efficient metabolite identification: Using knowledge-based expert systems to map Phase I and Phase II pathways with precision.
-
Integrated toxicity assessment: Identifying structure-toxicity relationships across 40+ endpoints (including mutagenicity and hepatotoxicity) for predicted metabolites.
-
Confident regulatory submissions: Building defensible evidence-based rationales to support ICH M7, ICH M3, MIST, and ICH S2 assessments.
-
Experimental data interpretation: Using in silico tools to interpret mass spectrometry data with higher confidence.
Who Should Join
While these sessions primarily cater for DMPK scientists, analytical chemists, and discovery leads tasked with prioritising drug candidates and building scientific justifications for regulatory decision-making, we welcome anyone interested in understanding more about metabolism of their compounds.
Register Your Interest
Stay updated on our upcoming schedule. Get notified of new sessions, receive exclusive content, and join a network of professionals advancing science with in silico knowledge.